Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients

Primary Objectives:

The primary objective of this study is to comprehensively assess the barriers to and facilitators of interventional clinical trial enrollment via in-depth interview of participants with pancreatic cancer among diverse backgrounds. The primary outcome will be identification of specific opportunities for improvement to increase study enrollment.

The above aim is part of a long-term multi-armed quality improvement project with the goal of increasing clinical trial enrollment among minority individuals with pancreas cancer. Using the data gained from this project, investigators aim to implement and tailor interventions towards addressing these barriers in conjunction with current scientific evidence. While the QI project is separate from this IRB submission, data gained from this specific research study will be crucial towards steering further improvement efforts.

Inclusion criteria

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

• Stated willingness to comply with all study procedures and availability for the duration of the study
• Males and females; Age ≥18
• Documented diagnosis of pancreatic cancer
• Access to necessary resources for participating in a technology-based intervention (i.e., computer, smartphone, internet access)

Exclusion criteria

An individual who meets any of the following criteria will be excluded from participation in this study:

• Patients who speak a primary language other than English or Spanish
• Patients who are cognitively impaired
• Pregnant women